HemaSphere (May 2023)
P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
- N. van de Donk,
- D. Cortes-Selva,
- T. Casneuf,
- D. Vishwamitra,
- S. Stein,
- T. Perova,
- E. Ramos,
- L. Van Steenbergen,
- R. Boominathan,
- O. Lau,
- C. Davis,
- A. Banerjee,
- T. Stephenson,
- C. Uhlar,
- R. Kobos,
- J. Goldberg,
- L. Pei,
- D. Trancucci,
- S. Girgis,
- S.X.W. Lin,
- L.S. Wu,
- P. Moreau,
- S. Usmani,
- N.J. Bahlis,
- R. Verona
Affiliations
- N. van de Donk
- 1 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
- D. Cortes-Selva
- 2 Janssen Research & Development, Spring House, PA, USA
- T. Casneuf
- 3 Janssen Research & Development, Beerse, Belgium
- D. Vishwamitra
- 2 Janssen Research & Development, Spring House, PA, USA
- S. Stein
- 2 Janssen Research & Development, Spring House, PA, USA
- T. Perova
- 2 Janssen Research & Development, Spring House, PA, USA
- E. Ramos
- 4 BioLizard, Ghent, Belgium
- L. Van Steenbergen
- 4 BioLizard, Ghent, Belgium
- R. Boominathan
- 2 Janssen Research & Development, Spring House, PA, USA
- O. Lau
- 2 Janssen Research & Development, Spring House, PA, USA
- C. Davis
- 2 Janssen Research & Development, Spring House, PA, USA
- A. Banerjee
- 2 Janssen Research & Development, Spring House, PA, USA
- T. Stephenson
- 2 Janssen Research & Development, Spring House, PA, USA
- C. Uhlar
- 2 Janssen Research & Development, Spring House, PA, USA
- R. Kobos
- 5 Janssen Research & Development, Raritan, NJ, USA
- J. Goldberg
- 5 Janssen Research & Development, Raritan, NJ, USA
- L. Pei
- 5 Janssen Research & Development, Raritan, NJ, USA
- D. Trancucci
- 5 Janssen Research & Development, Raritan, NJ, USA
- S. Girgis
- 2 Janssen Research & Development, Spring House, PA, USA
- S.X.W. Lin
- 2 Janssen Research & Development, Spring House, PA, USA
- L.S. Wu
- 6 Janssen Research & Development, South San Francisco, CA, USA
- P. Moreau
- 7 University of Nantes, Nantes, France
- S. Usmani
- 8 Memorial Sloan Kettering Cancer Center, New York, NY, USA
- N.J. Bahlis
- 9 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
- R. Verona
- 2 Janssen Research & Development, Spring House, PA, USA
- DOI
- https://doi.org/10.1097/01.HS9.0000936256.84340.a7
- Journal volume & issue
-
Vol. 7,
no. S2
pp. 28 – 29
Abstract
No abstracts available.